Morinaga Milk Industry has announced a €15 million (JPY 1.83 billion approx.) investment to more than double the lactoferrin production capacity of its German subsidiary Milei.
According to Morinaga, demand for lactoferrin – used in infant formula, supplements and other foods – has been growing, particularly in Western countries and Asia.
Following this investment, the lactoferrin production capacity of Morinaga’s German subsidiary is expected to increase to approximately 170 tons (more than double that of fiscal 2019).
According to data for 2019 from Absolute Reports, supplied by Morinaga, Milei already has the largest share of the global lactoferrin market in terms of production volume.
Morinaga Milk Group is aiming to increase the sales of its own lactoferrin-related products with the expansion of production capacity at Milei.
© FoodBev Media Ltd 2020